Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG

Clinical trial NCT06089122 · UNKNOWN

Trial details

NCT number: NCT06089122
Sponsor: Azidus Brasil
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Disease

Start date: 2024-04-01
Primary completion: 2025-01-08
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.